When do patients receive drug information monographs?

Patients receive drug information monographs when they are prescribed Risk Evaluation and Mitigation Strategy (REMS) medications. REMS is a program mandated by the FDA for certain medications that have significant risks in terms of safety, necessitating special precautions to ensure they are used safely. Providing a drug information monograph during the dispensing of REMS medications helps to ensure that patients are fully informed about the specific risks, benefits, and necessary monitoring associated with those drugs. These monographs are an essential part of the comprehensive approach to patient education, promoting safety and adherence to medication guidelines.

While patients may receive drug information monographs at other times, such as during medication check-ups or upon request, the requirement to provide this information as part of the REMS process highlights its critical role in safeguarding patient health for those particular medications.